• Chloride ions are strong positive allosteric modulators of mGlu 3 receptor.
Introduction
The amino acid L-glutamate is an essential element of life, and has been very early used as a messenger. During evolution, L-glutamate became one of the major neurotransmitters, being the mediator of the neuro-muscular junction in arthropods and being responsible for transmitting signals at most fast excitatory synapses in the brain (Fonnum, 1984) . Such an essential role of glutamate, associated with all the other functions of this amino acid, imposes a tight regulation of its extracellular concentrations. Indeed, an inaccurate control of extracellular glutamate levels can lead to epilepsy and brain damage through excitotoxicity (Meldrum, 2000) . Essential mechanisms have then been selected during evolution to monitor extracellular glutamate concentrations, including active uptake mechanisms and a control of glutamate entry at the level of the blood brain barrier. Defects in these mechanisms have been proposed to be responsible for a number of brain diseases, including neurodegenerative disorders as well as psychiatric diseases or addiction (Kalivas, 2009; Lewerenz and Maher, 2015; Miladinovic et al., 2015) .
Glutamate activates cationic glutamate-gated channels (i.e. ionotropic glutamate receptors) that mediate the fast excitatory actions of glutamate. It also activate G protein-coupled receptors, named metabotropic glutamate receptors (mGluRs) (Pin and Bettler, 2016) . The eight subtypes of mGluRs are key modulators of transmission at most synapses in the brain. Some mGluRs are located post-synaptically (the group-I mGlu 1 and mGlu 5 ), allowing a tight control of the post-synaptic response, while others (group-II, mGlu 2 & 3 , and group-III, mGlu 4, 7 & 8 ) are mainly found in pre-synaptic terminals where they inhibit the release of various neurotransmitters. Aside from the group-III mGlu 6 , which is responsible of the ON-bipolar neuronal transmission in the retina (Vardi et al., 2000) , mGluRs can be considered as glutamate sensors allowing cells to adapt their response as a function of the extracellular glutamate concentration. Indeed, mGluRs are not only found at glutamatergic synapses, but also at other types of synapses, including dopaminergic (DA) and GABAergic synapses, as well as in other regulatory cells such as astrocytes and microglial cells (Nicoletti et al., 2011) .
All mGluRs share a common structural architecture (Pin and Bettler, 2016) . They are obligate dimers, each protomer being composed of a large bi-lobed extracellular domain (ECD) containing a Venus Flytrap (VFT) and a cysteine-rich domain (CRD) that connects to the seven helices transmembrane spanning domain (TMD). The VFT domain binds orthosteric ligands and also endogenous allosteric modulators, notably extracellular ions, such as calcium and chloride, that potentiate receptor activity (DiRaddo et al., 2014; Jiang et al., 2014; Kuang and Hampson, 2006; Kubo et al., 1998; Tora et al., 2015; Vafabakhsh et al., 2015) .
The group-II mGlu 3 receptor is found at the post-synapse and in presynaptic elements in neurons and in astrocytes, facing the micro-vessels, making this receptor a likely key component of the detection of the extracellular glutamate concentration (Mudo et al., 2007; Ohishi et al., 1993; Tamaru et al., 2001 ). Genetic studies revealed a possible involvement of this receptor in various diseases, including schizophrenia and other psychiatric disorders (Consortium, 2014; De Filippis et al., 2015; Egan et al., 2004; Harrison et al., 2008; O'Brien et al., 2014) , as well as cancer development at the periphery (Kunz, 2014; Yi et al., 2017) . When compared to other mGlu receptor subtypes, mGlu 3 receptor often displays a strong basal activity in transfected cells, therefore limiting their full functional and pharmacological characterization.
The present study aimed to elucidate the structural and molecular basis of the high basal activity of the mGlu 3 receptor detected in heterologous system, a surprising property given its high structural similarity with the mGlu 2 receptor that does not display the same behavior. We demonstrate the existence of a unique allosteric interaction between glutamate and Cl − ions in the mGlu 3 receptor. This strengthened interaction network increases the stability of the glutamate-induced active state of the extracellular domain of the receptor, making the mGlu3 receptor highly responsive to low ambient glutamate concentrations Finally, we propose that this mechanism allows an accurate detection of sub-micromolar extracellular glutamate concentrations.
Material and methods

Cell culture and transfection
HEK293 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM, Life Technologies, Cergy Pontoise, France), supplemented with 10% of Fetal Bovine Serum (FBS) and were transiently transfected with rat mGluRs receptors by electroporation or reverse lipofectamine 2000 protocol as previously described (Doumazane et al., 2013) . Receptors were also co-transfected with the glutamate transporter EAAC1 to minimize influence of extracellular glutamate and if needed, chimeric G i /G q G-protein (G q TOP) to allow the coupling to the phospholipase C pathway for second messenger experiments. Cells were seeded in a poly-ornithine coated 96-well plate at the density of 150 000 cells/well. 24 h (48 h for chimeras) after transfection, medium was changed by Glutamax TM (Life Technologies, Cergy Pontoise, France) to reduce extracellular glutamate concentration 2 h before experiments.
Directed mutagenesis and chimeras constructs
mGlu 3 mutants receptors were obtained using the Quick-Change strategy (Stratagene, La Jolla, CA, USA). All mutations were made in the HA and HA SNAP encoding plasmids and were verified by sequencing. Total and cell surface expression was quantified by ELISA using anti-HA primary antibody coupled to peroxidase (3F10, Roche, Basel, Switzerland) as previously described (Goudet et al., 2004) . For chimeras receptors, a restriction site was introduced after the Venus Flytrap (VFT) encoding sequence in HA SNAP mGlu 2 and mGlu 3 plasmids using the Quick-Change strategy. Then, digested VFT sequences were sub-cloned into mGlu 2 or mGlu 3 plasmids according chimera design and final constructs were also verified by sequencing. Chimeras expression levels were quantified by fluorescence at 620 nm on Lumi4-Tb labeled receptors as described elsewhere (Doumazane et al., 2013) .
Chloride buffers composition
All chemical products were purchased from Sigma-Aldrich (L'Isle d'Abeau, France). Reference high Cl − buffer used for calcium mobilization, TR-FRET mGlu sensor and smFRET assays contained 154.6 mM of Cl − ions and included NaCl 150 mM, KCl 2.6 mM, MgSO 4 1.18 mM, D-glucose 10 mM, HEPES 10 mM, CaCl 2 1 mM and 0.5% (w/v) BSA. To reach 200 mM Cl − concentration, NaCl was increased. For buffers with lower Cl − concentration, NaCl and KCl were progressively replaced by gluconate equivalents (NaC 6 H 11 O 7 and KC 6 H 11 O 7 respectively). pH was adjusted at 7.4. It was previously shown that gluconate does not impair cell signaling (Tora et al., 2015) .
Second messengers assays
Inositol monophosphate production was determined using the IPOne HTRF (Homogenous Time Resolved Fluorescence) kit (Cisbio Bioassays, Codolet, France) according to the manufacturer's recommendations (Trinquet et al., 2006) . For the calcium mobilization assay, HA tagged mGluRs expressing cells were seeded in black-walled, clear bottom 96-well plates. High (154.6 mM) and low (2 mM) Cl − buffers supplemented with 4 mM probenecid were used. 24 h after transfection, cells were loaded with 1 μM of calcium sensitive fluorescent dye Fluo 4-AM (Life Technologies, Cergy Pontoise, France) diluted in fresh high Cl − buffer, for 1 h at 37°C. After washing, cells were maintained in 2 or 154.6 mM Cl − buffers prior glutamate addition.
Intracellular calcium release was determined using Flexstation ® (Molecular Devices, Sunnyvale, CA, USA). Fluorescence was detected for 60 s at 485 nm excitation and 525 nm emission. In order to assess gluconate side effects on cell signaling, Ca 2+ mobilization was also measured after stimulation of an AVP sensitive endogenous receptor on non-transfected cells, which was used as an internal control in each experiment, as previously described (Tora et al., 2015) .
TR-FRET mGlu sensor assay
SNAP tagged mGluRs were used for this assay. Cells were seeded in black-walled, black bottom 96-well plates. 24 h (48 h for chimeras) after transfection, receptors were covalently labeled with 100 nM of SNAP-Lumi4-Tb (donor) and 60 nM of SNAP-Green (acceptor) diluted in 154.6 mM high Cl − buffer. Donor and acceptor concentrations were chosen in order to label surface receptors equivalently, with both 1 donor and 1 acceptor molecule. After 1 h at 37°C, cells were washed in appropriate Cl − buffers and drugs were added. TR-FRET measurements were collected at 520 nm using PHERAstar F5 microplate reader as previously described (Doumazane et al., 2013 
smFRET experiments
For smFRET experiments, human SNAP tagged mGluRs extracellular domains (ECD) fused to a GPI anchor in the C-terminus (HA SNAP mGlu 3 Del570 GPI) were transiently co-transfected with glutamate transporter EAAC1 in HEK293 TSA cells by reverse Lipofectamine 200 protocol (Life Technologies, Cergy Pontoise, France), in 6-well plates. After 24 h expression, receptors were covalently labeled with 100 nM Benzyl-Guanine-Cy3B (donor) and 1 μM Benzyl-Guanine-d2 (acceptor) (Cisbio Bioassays, Codolet, France) diluted in fresh 154.6 mM high Cl − buffer for 1 h at 37°C. Then several washings with different Cl − buffers were performed prior to ECD cleavage using 0.25 U.ml −1 Bacillus cereus Phosphatidylinositol-specific Phospholipase C (Life Technologies, Cergy Pontoise, France), at 37°C for 30 min. ECD were purified using Zeba BSA. For smFRET measurements, samples were diluted to picomolar concentration and loaded into 384-well plates (Greiner Bio One). Data acquisition was performed on our home-built confocal MFD-PIE (Multiparameter Fluorescence Detection -Pulsed Interleaved Excitation) microscope (Olofsson and Margeat, 2013) as previously described (Olofsson et al., 2014 
Glutamate quantification
Medium from plated cells transiently expressing mGluRs with or without EAAC1 transporter was sampled for glutamate analysis at different experiment times: after 24 h expression, cells were washed one time and let 15 min in sensor assay buffer (high Cl − ); then 2 h or 5 h after medium change by Glutamax TM . Glutamax TM medium, IP-One and high Cl − Ca + /sensor assay buffers were also tested. Samples were filtered on 0.2-0.8 μm filters prior to analysis. Glutamate quantification was performed by a reversed phase narrow bore liquid chromatography assay with fluorescence detection after precolumn derivatization with o-phtalaldehyde and β-mercaptoethanol, as previously described (Van Hemelrijck et al., 2005) . The compounds were eluted by gradient elution with a mobile phase that was delivered at a rate of 0.17 mL/min. The gradient elution was performed using mobile phase A (0.025 M sodium phosphate solution pH 9 and 1% tetrahydrofuran) and mobile phase B (methanol:water 90:10). The temperature of the autosampler tray was set at 4°C and the injection volume was 10 μL on a C18 narrow bore column (5 μm particle size, 250 × 2 mm, Capcell Pak MG ® , Shiseido). Detection was performed with a RF 10 A XL fluorescence detector (Shimadzu) at excitation and emission wavelengths of 340 and 450 nm, respectively. Data acquisition was carried out with the integration computer program Clarity (DataApex, Antec, Zoeterwoude, the Netherlands). All analyses were performed at least in duplicate.
Structural and sequence analysis
Crystal structures of mGlu 2 (PDB 4XAQ) and mGlu 3 receptors (PDB 5CNK, 2E4U) were used to compare their VFT domains using the Discovery Studio 4.0 software (BIOVIA -A Dassault Systèmes brand -5005 Wateridge Vista Drive, San Diego, CA 92121 USA). For multiple sequence alignment, we used Discovery Studio's tool Align123 based on the ClustalW program (Thompson et al., 1994) . Sequences were obtained from Uniprot website (http://www.uniprot.org/), using the gene names for the queries, and only the sequence of the extra-cellular domain (ECD) was kept for the alignment. Output alignment was then further optimized.
Results
The glutamate binding domain is involved in the high basal activity of the mGlu 3 receptor
First, we compared the glutamate-induced production of second messengers by the different mGluRs. Receptors were transiently transfected in HEK293 cells and their glutamate-induced signaling responses were evaluated by measuring inositol monophosphate (IP1) production (Fig. 1A) . To allow the G i -coupled group-II and eIII mGluRs to activate the phosphoinositides pathway, receptors were co-transfected with a G i /G q chimeric G-protein. We found that the basal IP1 production was very high in mGlu 3 -expressing cells, in contrast to cells expressing other mGluR subtypes (p < 0.001), such that glutamate addition did not induce a significant increase of IP1 production.
To understand the structural origin of this phenomenon, we compared the activity of the mGlu 3 receptor to its closest relative mGlu 2 and built mGlu 2/3 receptor chimeras by inverting their VFT domains. We then measured their activity using both functional (IP1 production) and conformational mGluR sensors ( Table 1 ). These latter are based on VFT conformational changes occurring during receptor activation. SNAP-tags are inserted at the N-termini of each mGluR subunit and are covalently labeled with fluorescent dyes. Variation in distance between the fluorophores can be measured using Lanthanide Resonance Energy Transfer (LRET), using a Time-Resolved Förster Energy Transfer approach (TR-FRET) (Doumazane et al., 2013; Scholler et al., 2017) . Agonist binding induces closure of mGluRs VFT domains, leading to a reorientation of the protomers increasing the distance between the N-termini and so, resulting to a large decrease in the TR-FRET signals (Fig. 1D) .
In contrast to what was observed with the mGlu 2 receptor, glutamate concentration-response curves from mGlu 3 receptor-expressing cells were nearly flat in both the IP1 and TR-FRET assays ( Fig. 1B-C) . In vehicle conditions, the low FRET ratio measured for mGlu 3 receptors suggested most receptors were mainly in an active conformation, despite the lack of glutamate addition ( Fig. 1C , Supplemental Table 1 ). This result, combined with high IP1 levels in the same condition, highlights the high basal activity of mGlu 3 receptors. When mGlu 2 VFT was fused to mGlu 3 TMD (VFT2/TMD3 chimera), this basal activity was abolished and the receptor could be activated by glutamate similarly to the mGlu 2 receptor. In contrast, the fusion of mGlu 3 VFT with mGlu 2 TMD (VFT3/TMD2 chimera) showed an enhanced basal activity and a nearly flat glutamate concentration-response curve, similar to the mGlu 3 receptor (Fig. 1B -C, Supplemental Table 1 ). Taken together, these findings revealed that mGlu 3 VFT domain plays a key role in the high basal activity of the receptor.
Glutamate is required for the mGlu 3 receptor high basal activity
To explore the potential involvement of glutamate in the high basal activity of mGlu 3 receptors, we first measured conformational changes in presence or absence of the competitive antagonist LY341495 ( Fig. 2A) . Interestingly, in presence of LY341495, the FRET ratio is significantly increased (p < 0.001) in comparison to the ratio measured in the vehicle condition. These results suggest either that LY341495 is an inverse agonist, or that possibly it competes with (A) Signaling activity of the eight mGluRs quantified by inositol monophosphate (IP1) production under vehicle (VEH) or 1 mM glutamate (Glu) stimulation. HTRF ratio is inversely proportional to IP1 levels. Among all mGluRs, mGlu 3 receptor low HTRF ratio in vehicle condition suggests a high basal activity. Each data point corresponds to means ± SEM of 6 experiments. (B-C) Glutamate concentration-response curves of mGlu 2 and mGlu 3 receptors chimeras determined by IP1 (B) and TR-FRET mGlu sensor (C) assays. Contrary to mGlu 2 receptor (full circles), mGlu 3 receptor (full squares) concentration-response curve is nearly flat due to its high basal activity. This is abolished when mGlu 3 VFT is replaced by the one from mGlu 2 receptor (VFT2/TMD3 ambient glutamate present in the assay medium, preventing its action on the receptor.
We then designed a mutant mGlu 3 receptor less sensitive to glutamate. To that aim, we mutated the threonine in position 174, a key residue involved in the binding of the amino acid moiety of glutamate (Acher and Bertrand, 2005) , into an alanine. We then measured the conformational changes of mGlu 3 T174A in comparison to the WT mGlu 3 receptor. As expected, the mGlu 3 T174A construct was not activated by glutamate, except at high concentrations (1 mM) where a small decrease in the FRET ratio was measured. Interestingly, contrary to WT receptor, the mGlu 3 T174A mutant did not display any basal activity (Fig. 2B) . Decreasing receptor affinity for glutamate strongly reduces its basal activity, further supporting a key role of ambient glutamate provided by the cells in such an assay.
We quantified the ambient glutamate concentrations in cell media and buffers used for our experiments (Table 1 ). The glutamate concentration in cell medium is strongly affected by incubation time after transfection and co-expression of high-affinity glutamate transporter EAAC1. In optimized experimental conditions (i.e. EAAC1 coexpression and 2 h incubation in a glutamate-free cell medium before experiments, see Material and Methods section for details), a residual glutamate concentration of 0.59 ± 0.03 μM was measured.
To correlate this result to glutamate affinity, we performed binding experiments on mGlu 2 and mGlu 3 receptors expressing membranes (Supplemental Fig. 2 ). Radiolabeled LY341495 displacement curves indicated that the mGlu 3 receptor has a higher affinity for glutamate (sub-micromolar range, 0.90 ± 0.31 μM) compared to its homolog mGlu 2 receptor (10 μM range, 10.95 ± 6.92 μM). Of note, the glutamate Ki value of the mGlu 3 receptor calculated from binding experiments correlated to the extrapolated potency derived from conformational sensor experiments in Fig. 3 (0.88 vs. 0.90 μM) (Supplemental Table 2 ). According to the glutamate concentration in the assay, we can deduce that about 40% of the receptors are occupied in these conditions.
Altogether, these results are highlighting that high basal activity likely of the mGlu 3 receptor results mainly from receptor activation by ambient glutamate.
Extracellular chloride modulates both basal and agonist-induced mGlu 3 receptor activity
We have previously reported the positive allosteric modulation of mGluRs' activity by Cl − (Tora et al., 2015) , with the mGlu 2 receptor being the less sensitive to extracellular Cl − as compared to other mGluRs. In that study, the effect of Cl − on mGlu 3 receptor was not considered. However, another study proposed that Cl − ions could directly activate mGlu 3 receptor (DiRaddo et al., 2015) . In the light of these findings, we thus examined the effect of extracellular Cl − on mGlu 3 receptor basal and agonist-induced activity. First, the receptor activity was measured both by functional (intracellular Ca 2+ mobilization) and conformational assays (TR-FRET mGlu sensor assay) in two different buffers containing either a physiological (154.6 mM, referred to "high Cl − ") or a low Cl − concentration (2 mM, referred to "low Cl A.S. Tora et al. Neuropharmacology 140 (2018) 275-286 the glutamate concentration-response curve of mGlu 3 was nearly flat in high Cl − buffer, whereas a robust dose-dependent activation of mGlu 3 receptors by glutamate can be observed in the low Cl − buffer (Supplemental Fig. 3 Supplemental Table 2 ). In the conformational assay, a concentration-dependent change of FRET signal was observed in both high and low Cl − buffers (Fig. 3A) . However, in the basal condition, the TR-FRET ratio in the high Cl − buffer is approximately half of the ratio observed in the low Cl − buffer (Fig. 3A , Supplemental (Fig. 3C) . At EC 80 , Cl − potency was estimated to 30.98 mM, indicating a strong positive modulation on mGlu 3 receptors. The Hill slope value was 1.11 ± 0.24, suggesting Cl − effect may occur predominantly at one binding site.
Interestingly, in absence of glutamate addition, Cl − concentration-response curve was not well defined, but Cl − potency could be extrapolated to 470.10 mM, a concentration far above the physiological range which is considered to be around 120 mM (Jiang et al., 1992) . Taken together, these findings indicate mGlu 3 receptor is highly modulated by Cl − , in contrast to its homolog mGlu 2 (Fig. 3D ). We then measured conformational changes in presence or absence of the competitive antagonist LY341495 in low and high Cl − buffers (Fig. 3E) 
Chloride ions favor agonist-induced conformational change of the mGlu 3 receptor
To better understand the consequence of Cl − modulation on the receptor, we further analyzed the glutamate-induced conformational changes at the single molecule (smFRET) level in comparison to the ensemble level (TR-FRET) (Fig. 4) . Compared to ensemble FRET, smFRET allows the measurement of sub-millisecond conformational dynamics, thus providing a more accurate analysis of receptor activation mechanisms (Olofsson et al., 2014) . We used isolated SNAP-tagged mGlu 3 extracellular domains (ECD) for smFRET experiments, as previously described for mGlu 2 receptors (Olofsson et al., 2014) . This glycosylphosphatidyl inositol (GPI)-fused construct is cleaved by phospholipase C (PLC) in order to produce soluble ECDs, labeled with smFRET compatible fluorophores (Fig. 4B, upper panel) . Like full-length receptors, soluble ECDs oscillate between an active and an inactive state. This conformational equilibrium is affected by ligand binding, therefore shifting the apparent FRET efficiency (E PR ) of the main population in smFRET experiment on diffusing molecules (Fig. 4B, lower panel) . Moreover, the use of highly diluted solutions of purified ECDs allows working with solutions containing very low ambient glutamate concentrations.
We tested the effect of Cl − concentrations (2, 75 and 154.6 mM) on basal conditions (vehicle) or following glutamate addition on WT (Fig. 4A and C, Supplemental Fig. 4) . Therefore, the Cl − ion appears as a strong positive allosteric modulator of the mGlu 3 receptor but did not display agonism by itself. Taking together, these results further confirm that the basal activity of mGlu 3 is due to the receptor's high affinity for glutamate and Cl − potentiation of glutamate binding.
A unique "chloride lock" stabilizes the active state of the mGlu 3 receptor
To delineate a molecular basis of the mGlu 3 receptor's Cl − -related basal activity, we examined the crystal structures of mGlu 3 and mGlu 2 VFTs (PDB 5CNK and 4XAQ, respectively), recently solved in their dimer active closed conformation (Acc) binding the potent agonist LY354740 and glutamate (Glu) respectively (Monn et al., 2015a (Monn et al., , 2015b (Fig. 5) .
A first difference resides in the number of Cl − binding sites in mGlu 2 and mGlu 3 VFTs. Several halide sites can be observed in mGlu 3 VFT (Fig. 5A-B) . Among them, two sites correspond to functional Cl − binding sites that have been described in the VFT of most mGluRs, contrary to the mGlu 2 receptor, which possesses only one of these functional sites (Tora et al., 2015) . The first Cl − site (Site 1) is located within VFT lobe 1, in a binding pocket adjacent to the glutamate binding site, which was previously predicted (Acher et al., 2011) and demonstrated to be a Cl − binding site conserved in all mGluRs (Supplemental Fig. 6A ) (DiRaddo et al., 2015; Tora et al., 2015) . The second site (Site 2) is created by the interface of both VFT lobes, when the receptor is in a closed active conformation and shows more divergence within the mGluR family. This binding site is absent in mGlu 2 where the S152 that is critical for Cl − binding in site 2 is replaced by an aspartate residue (Tora et al., 2015) . Another major difference between mGlu 2 and mGlu 3 VFT appears at α-helix 7 and loop 7 (Fig. 5A-B and Supplemental Fig. 6 ). Whereas loop 7 adopts a straight conformation in mGlu 2 , it is longer and curled in mGlu 3 because of α-helix 7 unfolding. This occurrence results in a critical difference at the dimer interface between the Acc protomers, which allows several additional interactions with the facing monomer. A closer look at the mGlu 3 structures suggests that Cl − bound at site 2 could coordinate this network of interactions between the two lobes, tightening the closed VFT. In particular, Cl − may bridge S152 (lobe 1, loop 3) and R277 (lobe 2, loop 8) in the agonist-induced closed VFT conformation (Fig. 5C-D right panel) . Due to the ionic nature of the chloride, the interaction between S152 and R277 is stronger compared to that with a neutral water molecule (Rozas et al., 2008) (Fig. 5D  central and right panel) . Thereby, Cl − may act as a "Cl − lock" for smFRET, 1 mM); GPI: Glycosylphosphatidyl inositol; LY34, LY341495; n.s.: non significant; PLC: Phospholipase C; TMD: transmembrane domain; VEH, vehicle.
A.S. Tora et al. Neuropharmacology 140 (2018) 275-286 underlying the high agonist affinity by stabilizing the glutamate-induced closed conformation of mGlu 3 VFT (Figs. 5 and 6 ).
To verify our hypothesis, we mutated mGlu 3 S152 that seems to be crucial in Cl − binding into an aspartate (as in mGlu 2 ) or an alanine and measured receptor activation by TR-FRET assay and signaling activity by Ca 2+ mobilization ( Table 2 ). Glutamate potencies of mGlu 3 S152A and mGlu 3 S152D were not changed compared to the WT receptor in high Cl − buffer (Supplemental Fig. 6B ). However, both S152A and S152D mutations abolished the receptor's basal activity. Indeed, FRET ratios measured in high Cl − were similar to the WT receptor in low Cl − (Supplemental Fig. 6C ). Ca 2+ mobilization data indicated signaling activity was rescued for both mutants in high Cl − buffer, in comparison to the WT (Supplemental Fig. 6C ). Regarding Cl − sensitivity, the mGlu 3 S152D mutant exhibited a reduced Cl − sensitivity, similar to the mGlu 2 receptor (Supplemental Table 2 ). Mutations did not change expression of the receptor (Supplemental Fig. 6D ). Taken together, these data confirmed the involvement of Cl − binding site 2 in mGlu 3 receptor's activity and unravel the key role of S152 on ion stabilization. At a molecular level, these data may be interpreted in terms of stability of the active conformation of the receptor. With the mutants S152D and S152A of the mGlu 3 receptor, the most stable network is similar to that at low Cl − concentrations and the high basal activity is thus not observed, resembling to what happens at mGlu 2 receptors.
Discussion
In this study, we investigated the molecular mechanisms underlying the atypical high-basal activity observed in cells expressing the mGlu 3 receptor. Our main finding shows that it is not corresponding to a constitutive activity of the mGlu 3 receptor in the absence of bound agonist. Instead, it results mostly from a Cl − -mediated amplified response to low ambient glutamate concentrations, such as those measured in cell media. This strong positive allosteric modulation of glutamate by Cl − ions allows the mGlu 3 receptor to sense and efficiently react to sub-micromolar concentrations of glutamate, making it the most sensitive member of mGluR family. Ion dependence of mGluRs activity has been previously reported, notably to Ca 2+ and Cl − (Kuang and Hampson, 2006) . While mGlu 1
and mGlu 3 receptors were demonstrated to be sensitive to Ca 2+ , Cl − modulation was reported for all mGluRs, with a lesser extent for the mGlu 2 receptor (DiRaddo et al., 2014; Jiang et al., 2014; Tora et al., 2015; Vafabakhsh et al., 2015) . Of note, the cooperativity between an amino acid ligand and ions to stabilize the active conformation of the receptor is also observed in another receptor from the GPCR class C, the Halides at site 1 and 2 as defined in Tora et al., (2015) , are displayed with van der Waals spheres. In mGlu 2 receptor, α-helix 7 holds 4 turns (colored in red and orange for the first turn) and loop 7 (between β-strand 7 and α-helix 7) adopts a straight conformation (orange). In mGlu 3 receptor, α-helix 7 is made of only 3 turns (colored in red) as turn 1 is unfolded allowing loop 7 (in orange) to curl. Cα distances are displayed between green chain (Glu222 for mGlu 2 receptor, Glu228 for mGlu 3 receptor) and blue chain (Ser 246 and Val 253 for mGlu 2 receptor, Ile252 and Val259 for mGlu 3 receptor).
The hairpin structure preceding α-helix 1 (I47 to N61) is named loop 1 and colored in purple. (C) mGlu 2 receptor (left panel): R243 (loop 7 in lobe 2) is tightly bound to D95 (loop 2 between β-strand 2 and α-helix 2) and D146 (loop 3 between β-strand 3 and α-helix 3) in lobe 1 by two salt bridges, mGlu3 receptor (right panel) R249 is not binding to D102 (loop 2), the homologous residues to mGlu2 D95 but to the carbonyl of G51 of loop 1 which is possible because of the twisted loop 7 in the active dimer. This distortion allows several inter-dimer interactions: I252 with A176, R253 and K 246 with E228. (D) . The closed mGlu2 VFT is further stabilized by an ionic interaction between D146 (loop 3) and R271 (loop 8 between β-strand 8 and α-helix 8) and a cation-Π interaction between Y144 (loop 3) and R271 in mGlu 2 receptor (left panel). In mGlu 3 receptor, a similar cation-Π interaction between Y150 and R277 is present in the Resting closed dimer conformation, Rcc (PDB structure 2E4U) and in the Acc conformation (central and right panel). However, the distance is too long between S152 and R277 for a direct interaction. It is mediated by a water molecule (red atom, central panel) in the Rcc conformation or by a halide (iodide in 5CNK, violet atom, right panel) ion in the superstable Acc conformation (Supplemental Fig. 7 ). Atom color code: C chain color, N blue, O red, Cl green, I violet. (E) Mutations of S152 in mGlu3 into an alanine (S152A, squares) or aspartate (S152D, triangles) both reduce receptor basal activity without significantly reducing glutamate potency in TR-FRET sensor assay. Each data point corresponds to mean ± SEM of 6-11 experiments (see details in Supplemental Fig. 2 ). Concentration-response curve parameters are listed in Supplemental Table S2 . Glu: glutamate; VEH: vehicle. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) Ca 2+ sensing receptor. This receptor is activated concomitantly both by Ca 2+ ions and an L-amino acid, such as L-Phe, that binds in a pocket corresponding to the glutamate binding pocket in mGluRs . Here, we showed that the mGlu 3 receptor is particularly strongly potentiated by Cl − ions as compared to other mGluRs. This strong positive cooperativity between Cl − ions and glutamate occurs through a unique strengthened interaction network between the two lobes of the extracellular domain of the mGlu 3 receptor. This network acts as a "Cl − -lock" that dramatically reinforces glutamate binding and function. Previously, both Ca 2+ and Cl − ions were proposed to display agonist activity on the mGlu 3 receptor (DiRaddo et al., 2015; Vafabakhsh et al., 2015) . However, in our experiments, Cl − per se does not display direct agonism, as revealed by the glutamate insensitive mGlu 3 mutant T174A, which is not activated by Cl − . We propose that what has been interpreted previously as Cl − direct agonism in very sensitive assays may correspond in fact to the potentiation by Cl − ions of the activity induced by residual ambient glutamate. Indeed, cells are constitutively releasing glutamate in extracellular media. We have recorded concentrations ranging from 0.6 to more than 5 μM. These glutamate concentrations are in line with those measured in another recent publication (Doornbos et al., 2018) . Thus, Cl − ions are pure positive allosteric modulators of the mGlu 3 receptor. It is unlikely to observe the occurrence of rapid Cl-concentration changes compatible with dynamic modulation of mGlu 3 receptor activity. Short-term variations occur during transport or synaptic activities where rapid Cl − fluxes through GABA or glycine-gated ion channels modify Cl-concentrations (Staley et al., 1995) . We have previously evaluated the discrete variations of Cl − concentrations in the synaptic cleft during GABAergic events in physiological or pathological conditions (Tora et al., 2015) . We found that multiple synaptic events can modify synaptic Cl − concentrations up to 25 mM. Long-term changes in Cl − concentrations can be observed during maturation (Ben-Ari et al., 2007) , modifications of extracellular matrix (ECM) and pathologies (De Koninck, 2007; Kaila et al., 2014) . Interestingly, fast extracellular Clchanges due to synaptic activity and slow changes could be additive. Thus, in particular conditions, such as anoxia where variations of Clexceeding 30 mM can be observed (Jiang et al., 1992) , Cl-variations could reach up to 55 mM. However, given the potency of Cl − on the mGlu 3 receptor (∼30 mM) as compared to the physiological extracellular Cl − concentration in mature CNS (∼120 mM), the potentiation of mGlu 3 receptor activity by Cl − ions is probably mostly constitutive.
Other members of the mGluR family could be dynamically regulated by Cl − , such as the presynaptic mGlu 4 receptor (Tora et al., 2015) . Indeed, unlike the mGlu 3 receptor, mGlu 4 presents characteristics that makes it more susceptible to be actively regulated by discrete Cl − variations.
First, this receptor is expressed in GABAergic synapses where rapid Clvariations occur following opening of GABA A receptors. Second, the potency of Cl − on mGlu 4 receptoris close to the physiological Cl-concentration (∼80 mM) and presents a steep relationship between Cl − and glutamate-induced activity (with an N Hill ∼6). This means that small changes in Cl − concentration yield to large changes in response to glutamate. On the other hand, dramatic changes in Cl − homoeostatis occur during CNS maturation (Ben-Ari et al., 2007) . We can hypothesize that mGlu 3 receptors should shift from a "dynamic" mode of glutamate response during the early stages to the highly-glutamate sensitive and sustained response mode described in the present study in mature stages. This should affect its biological functions in early stages, such as the crucial control of mGlu 5 -mediated neuroprotection described in Di Menna et al. (Di Menna et al., 2018) . One can hypothesize that when extracellular Cl − concentrations are low in premature stages, mGlu 3 receptor should be able to signal and regulate the release of neurotrophic factors from astrocytes, given its high Cl − sensitivity.
However, in the absence of specific data this remains purely speculative and further investigations will be needed to evaluate the impact of Cl − on mGluR function in the premature brain. In the mature brain, while it is unlikely to observe the occurrence of Cl − concentrations changes compatible with a significant modulation of mGlu 3 receptor activity, a Cl-mediated rapid adaptation of the regulatory role of some mGluRs, such as mGlu 4 receptors present on GABAergic terminals, could be observed.
Although the overall structures of mGlu 2 and mGlu 3 VFTs are highly similar, two major differences can be observed: (i) the number of functional Cl − binding sites, one in mGlu 2 versus two in mGlu 3 receptors and (ii) the loop 7 in lobe 2 is longer in mGlu 3 than in the mGlu 2 receptor. These two particularities of the mGlu 3 receptor contribute to the building-up of a unique "Cl − lock" that greatly stabilizes the glutamate-induced closed conformation of its VFT. Indeed, as compared to mGlu 2 , the presence of Cl − in site 2 in mGlu 3 receptor is coordinating a network of interactions between the two lobes, involving notably the twisted loop 7, that is tightening the closed VFT. As a result, the atypical high-basal activity of the mGlu 3 receptor is not observed in the cognate mGlu 2 receptor in which the Cl − lock is absent. The residue S152 seems to play a crucial role in Cl − binding and bridging between the lobes. This amino acid was previously reported to be involved in mGlu 3 Ca 2+ -based basal activity (Kubo et al., 1998; Vafabakhsh et al., 2015) , but no Ca 2+ ion was found in crystal structures at this location.
Regarding literature, Ca 2+ seems to play a role in mGlu 3 receptor activity, but its binding(s) site(s) as well as its contribution to the receptor's basal activity remains unclear. In contrast, in the mGlu 2 receptor, the corresponding serine residue is mutated into an aspartate (D146), which disrupts Cl − binding at site 2, explaining divergence with mGlu 3 receptors towards both Cl − sensitivity and basal activity.
Prior to this study, D146 has been proposed to disrupt the cation-pi interaction and also the Cl − binding site 1, by engendering a flip of R271 (so called "arginine flip"), thus postulating there would be no Cl − binding sites in mGlu 2 (DiRaddo et al., 2015) . However, in recently released mGlu 2 VFT crystal structure (Monn et al., 2015b) , the cation-pi interaction is intact and only one Cl − ion is found in site 1, which is consistent with our previous study and the present data (Tora et al., 2015) . In addition, it is worth to mention that another Cl − ion is localized near the cation-pi in this structure, but at a different site from site 2, as it is found in only one protomer and therefore may be a crystallization artefact. Additional inter-lobe connections may also participate to the closed VFT stabilization, such as R249 (lobe 2, loop 7), which can bind to G51 (lobe 1, loop 1) in mGlu 3 receptors because of the unfolding of the α-helix 7 and a new conformation of loop 7 ( Fig. 5C and D right panels) . The H-bond between R249 and G51 carbonyl is weaker than the salt bridge with D102 that occurs in mGlu 2 ( Fig. 5C and D left panels), nevertheless this loss of stability is compensated by new interactions at the dimer interface between loop 7 and helix 6 of the other monomer (See Fig. 6 and Supplemental Fig. 5 ). This interaction network could possibly explain why the two mGlu 3 VFT monomers are closer than those of mGlu 2 . One can speculate that this proximity may further increase the stability of the active dimer resulting in the basal activity of the receptor at low glutamate concentrations. However, further studies will be necessary to determine more precisely the dimer interface and its involvement in receptor activation. The specific pathophysiological roles of the mGlu 3 receptor are still poorly understood. Until recently, these studies have been hampered by the lack of selective tools discriminating between the cognate mGlu 2 and mGlu 3 receptors. Indeed, the orthosteric binding sites of these two receptors are 100% identical, making the identification of selective orthosteric ligands highly challenging. Thus, the first ligands available were selective for the group II mGluRs over other groups, but failed to discriminate between mGlu 2 and mGlu 3 receptors (Celanire et al., 2015) . Still, mGlu 2/3 ligands have been very helpful to highlight the involvement and the therapeutic potential of these receptors in different CNS disorders, notably in anxiety, schizophrenia, addiction, depression and chronic pain. Recently, several selective mGlu 3 negative allosteric modulators (Engers et al., 2015) or orthosteric ligands (Monn et al., 2015b (Monn et al., , 2018 have been identified. The selectivity of these newly discovered orthosteric ligands lies behind their interaction with amino acids residing at the periphery of the glutamate binding site of the mGlu 3 receptor (Monn et al., 2018) . Indeed the crystal structure of LY2794193, a selective mGlu 3 agonist, bound to mGlu 3 VFT (PDB ID 6B7H) reveals that its methoxyphenyl substituent pushes away R277 but does not prevent the stabilization of the active dimer with the curled loop7 (Supplemental Fig. 7) (Monn et al., 2018 (Goudet et al., 2012; Selvam et al., 2018) . Hopefully, new selective ligands will help to better define the particular roles of mGlu 3 receptors. Interestingly, mGlu 2 and mGlu 3 receptors differ notably by their cellular distribution. Whereas mGlu 2 receptors are mostly neuronal, mGlu 3 receptors are expressed both in glia and in neurons. In neurons, mGlu 3 receptors are present at the post-synapse and in presynaptic elements (Tamaru et al., 2001) where their activation reduces synaptic activity and plasticity (Harrison et al., 2008) . Interestingly, a functional partnership between neuronal mGlu 3 receptors and mGlu 5 receptors has recently been described, in which activation of mGlu 3 receptors amplifies mGlu 5 receptor signaling and shapes the ability of mGlu 5 receptors to either amplify or restrain neuronal toxicity (Di Menna et al., 2018) . In astrocytes, mGlu 3 receptors have been shown to regulate important functions such as the release of astrocytic glutamate and other factors (Aronica et al., 2005; Corti et al., 2007; Nicoletti et al., 2015) , the re-uptake of glutamate (Aronica et al., 2003) , nitrate homeostasis (Wang et al., 2016) and are involved in neuroprotection Corti et al., 2007) . By promoting glutamate sensing in the extracellular space, through the molecular mechanisms described in this study, the mGlu 3 receptor could react effectively to concentrations of glutamate below the micromolar range. This might confer mGlu 3 receptor the ability to regulate the basal tone of glutamate release from neuronal presynaptic elements, as well as basal release of neuroprotective factors, thereby participating to the fine regulation of glutamate reuptake by glia.
Given the numerous physiological and pathological actions of glutamate, it is crucial to control acutely extracellular glutamate concentrations in the brain. Indeed glutamate becomes neurotoxic at elevated extracellular concentrations and glutamate dysregulation is associated to many CNS disorders. Different actors ensure the control of glutamate homeostasis. Transporters are maintaining low concentrations of synaptic and extrasynaptic glutamate. While ionotropic glutamate receptors are responsible of the fast-synaptic response to glutamate, mGluRs are responsible for its slow neuromodulatory actions. Group I mGluRs positively modulate responses to glutamate while group II and group III receptors are decreasing neuronal activity by downregulating the release of neurotransmitters. Interestingly, the eight members of the mGluR family display different affinities for glutamate. Three members present submicromolar affinity for glutamate: mGlu 1 with 0.3 μM Thomsen et al., 1993) , mGlu 5 with 0.5 μM and mGlu 3 which Ki values range from 0.041 to 0.9 μM (Johnson et al., 1999; Laurie et al., 1995; Schweitzer et al., 2000) and 0.9 μM in the present study. While the mGlu 3 receptor affinity for glutamate is in the same range than the ones of mGlu 1 or mGlu 5 receptors, its relatively high glutamate affinity combined to its unique Cl − lock favoring the agonist-induced state makes the mGlu 3 receptor able to sense and fully respond to submicromolar glutamate concentrations. This could enable mGlu 3 receptors to play a role in the regulation of basal conditions with low tone of glutamate. Other members of the family, mGlu 2 , 4, 6 and 8 receptors present intermediate affinities, in the micromolar range, for glutamate, (Cartmell et al., 1998; Eriksen and Thomsen, 1995; Schweitzer et al., 2000; Wright et al., 2000) . On the opposite side of the spectrum, the mGlu 7 receptor is activated by millimolar concentrations of glutamate, with an affinity around 900 μM (Wright et al., 2000) . This receptor is located in the synaptic grid where glutamate is released and can reach occasionally such high concentrations. Contrary to mGlu 3 receptor, the role of mGlu 7 receptor would then be to react to the highest concentrations of glutamate and may ensure a role of safety valve. This mGluRs large spectrum of glutamate sensitivity associated to their widespread synaptic, non-synaptic and glial distribution allows them to participate to a fine neuroadaptation of the CNS.
In conclusion, we demonstrated that the atypical high-basal activity of the mGlu 3 receptor results mostly from its activation by low ambient glutamate concentrations. This is due to a unique interaction network located in the extracellular domain of the mGlu 3 receptor. This network acts as "Cl − lock" that is strongly stabilizing the glutamate-induced active conformation of the receptors. This strong allosteric control of the mGlu 3 receptor by physiological Cl − ions allows it to sense and respond efficiently to low concentrations of glutamate. Thus, the various mGluR subtypes appear as a family of glutamate sensors able to respond to a wide range of conditions, from high nanomolar to millimolar concentrations of glutamate. Among them, mGlu 3 receptor is the most sensitive member of this family, able to mediate sustained responses to low tone of glutamate.
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